Explore company profiles, quarterly results, announcements and ownership disclosures.
Loading the company view…
Indoco Remedies Limited (NSE: INDOCO), ISIN INE873D01024 — earnings, PEAD surprise, concall summary, Walk-the-Talk management consistency, SAST and insider filings, and the EquiSense Score (ECS), all in plain English on EquiSense.
INDOCO last traded at ₹216.70 (+0.76%), with a 52-week range of ₹162.19 to ₹287.80 (as of 6 Nov 2026).
Shareholding as of Sep 2026: promoters 58.92%, FIIs 1.64%, DIIs 16.64%, mutual funds 16.44%.
EquiSense Score (ECS): 55/100.
Data sourced from NSE and BSE filings. Educational — not investment advice.